# HELICON THERAPEUTICS INC — Form D

HELICON THERAPEUTICS INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-06-26. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-06-26
- Form: D
- Accession: 0001133196-09-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 1
- Date of first sale: 2009-05-22
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-55393

## Issuer

- Name: HELICON THERAPEUTICS INC
- CIK: 0001133196
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 7473 LUSK BLVD., SAN DIEGO, CA, 92121
- Phone: 858-246-8120

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth Dart | Director | San Diego, CA |
| Jonathan Gelles, D. Phil. | Director | San Diego, CA |
| Kenneth E Johns, Jr. | Director | San Diego, CA |
| Tim Tully, PhD. | Director | San Diego, CA |
| Kenneth E Johns, Jr. | Executive Officer | San Diego, CA |
| Tim Tully, PhD. | Executive Officer | San Diego, CA |

## More

- [CIK 1133196 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1133196&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001133196-09-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.